老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.22
+0.02001.67%
成交量：16.95万
成交额：20.74万
市值：1,568.08万
市盈率：-1.12
高：1.24
开：1.23
低：1.22
收：1.20
数据加载中...
总览公司新闻公告
2019/06/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/05/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

招股说明书

Registration statement for certain foreign private issuers
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/20

SEC问询函

[Cover]Correspondence
2019/03/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
更多